CD16+ Monocytes From Severe COVID-19 Cases Compared to Those From Mild Cases Have Dysregulated Protein Synthesis and Antigen Presentation Gene Expression, and Increased Expression of Apoptosis Related Genes. This evidence concerns the gene FCGR3A and COVID-19.